Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Teva and Alvotech announced that the U.S. Food and Drug Administration (FDA) approved SELARSDI (ustekinumab-aekn) injection as ...

In the role of liquidity provider, DNB Carnegie undertakes to continuously quote prices for Alvotech's SDRs in accordance ...

Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This ...

Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This ...

One of Iceland's largest companies, the pharmaceutical firm Alvotech, has announced its intention to list on Nasdaq Stockholm ...

Selardsdi is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...

Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the ...

Truecaller AB Series B posted the largest decline among large stocks during the session, plunging 12.2%, followed by Sagax AB Series A shares, which plunged 11.5%. Shares of Zealand Pharma A/S ...

REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the "Company"), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...